Table 1.
Clinical and pathological features of the study cohort
| CRC patients | |
|---|---|
| Number | 45 |
| Median age [range] | 56 [18–79] |
| Gender [Male/Female] | 30:15 |
| TNM stage | |
| I | 4 |
| II | 20 |
| III | 14 |
| IV | 7 |
| Tumor histological grade | |
| G2 (Moderately differentiated) | 41 |
| G3 (Poorly differentiated) | 4 |
| MSI-H/dMMR | 8 |
| Loss of nuclear expression for MLH1 & PMS2 | 7 |
| Loss of nuclear expression of MSH2 | 1 |
| Molecular testing | |
| KRAS mutations | 4 |
| BRAF mutations | 1 |
| NTRK gene fusion | 1 |
CRC Colorectal cancer, MSI-H/dMMR high microsatellite instability /deficient mismatch repair